This second edition of the guide features updated information about newer psychotropic agents, as well as new drugs to help manage iatrogenic weight gain, metabolic dysregulation, involuntary movement disorders, and other common problems. New tables and figures have also been added to aid rapid assessment and management, and the self-assessment section has been updated and expanded with more key questions to facilitate knowledge retention.
Regardless of their particular expertise, all clinicians will benefit from the rigorous scientific and scholarly discussion they will find in this edition of the consequences of drug therapies they prescribe, the range of available strategies to effectively manage adverse effects, and the scientific and practical implications of their treatment decisions.
